Co-Diagnostics has grown its mosquito abatement district customer base to 21 states, adding four new full laboratory installations in June. This expansion supports faster, decentralized PCR testing for mosquito-borne diseases like West Nile virus, aiding local health agencies in timely surveillance and control. The move coincides with National Mosquito Control Awareness Week and reflects growing urgency due to rising vector-borne disease risks. Co-Diagnostics aims to enhance public health responses by enabling quicker, data-driven decisions through its Vector Smart products.
Jyske Realkredit A/S announced fixed coupon rates for several bond series effective from July 1 to September 30, 2026. The rates range from 2.31% to 2.92% per annum depending on the bond series. This update informs investors about the expected return...
Jyske Realkredit A/S announced the fixed coupon interest rates for several bond series effective from July 1, 2026, to September 30, 2026. The rates range from 2.31% to 2.92% per annum depending on the bond series. This update informs investors about...
Nyrstar NV released a legal opinion addressing the impact of its potential dissolution and liquidation on ongoing criminal cases and its ability to pursue claims against responsible third parties. This follows a notice from the FSMA and aims to clari...
Nyrstar NV has published a legal opinion from external lawyers regarding the impact of a potential company dissolution and liquidation on an ongoing criminal procedure and the company's ability to protect its rights by possibly filing claims against ...
Oblenio Bio secured $62 million in a Series B funding round led by Pfizer Ventures to support clinical development of LBL-051, a tri-specific T-cell engager targeting autoimmune diseases. LBL-051 aims to reset the immune system by depleting B-cells a...
